Sakari Kauppinen

Sakari Kauppinen is a Professor at the Department of Clinical Medicine, Faculty of Medicine, Aalborg University. His research focuses on microRNA biology, therapeutic applications, and their roles in diseases such as cancer, neurodegeneration, and metabolic disorders. He leads projects like the 2024 initiative exploring microRNA-22’s role in Duchenne Muscular Dystrophy. Notable contributions include pioneering microRNA-targeted drugs and advancing antisense oligonucleotide technologies. His work spans from basic RNA mechanisms to clinical translation, with collaborations in drug development and biomarker discovery. Kauppinen’s team is part of the Center for RNA Medicine, emphasizing interdisciplinary research in RNA-based therapies.

Education details are not explicitly stated, but his career reflects advanced expertise in molecular biology and pharmacology. Key research interests include RNA interference mechanisms, microRNA regulatory pathways, and their modulation in disease contexts. He has authored over 70 publications, including seminal reviews on microRNA therapeutics and patents for innovative nucleic acid compounds. Media highlights include discussions on RNA medicine’s potential post-Nobel recognition and contributions to grants like the Novo Nordisk Foundation funding.

Labs/Teams: Active member of the Center for RNA Medicine at Aalborg University. Collaborative projects involve institutions globally, focusing on translational RNA research.